BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 10098431)

  • 61. Definitive radiotherapy combined with high-dose-rate brachytherapy for Stage III carcinoma of the uterine cervix: retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters.
    Takeshi K; Katsuyuki K; Yoshiaki T; Teppei S; Tadayoshi M; Akira M; Katsumi M
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):319-27. PubMed ID: 9607347
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
    Sorbe B; Bohr L; Karlsson L; Bermark B
    Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rapid involution and mobility of carcinoma of the cervix.
    Lee CM; Shrieve DC; Gaffney DK
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):625-30. PubMed ID: 14751536
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Survival and toxicity of radical radiotherapy (with or without brachytherapy) for FIGO stage I and II cervical cancer: a mono-institutional analysis.
    Bandera L; La Face B; Antonioli C; Galelli M; Ghedi B; Fiume A; Buglione M; Magrini SM; Sartori E
    Eur J Gynaecol Oncol; 2014; 35(2):121-7. PubMed ID: 24772912
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
    Kapp KS; Poschauko J; Tauss J; Berghold A; Oechs A; Lahousen M; Petru E; Winter R; Kapp DS
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1399-404. PubMed ID: 16029799
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.
    Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tumor heterogeneity of FIGO stage III carcinoma of the uterine cervix.
    Kim YB; Lee IJ; Kim SY; Kim JW; Yoon HI; Kim SW; Kim S; Kim YT; Suh CO; Kim GE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1323-8. PubMed ID: 19467800
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High dose rate brachytherapy for carcinoma of the uterine cervix: comparison of two different fractionation regimens.
    Le Pechoux C; Akine Y; Sumi M; Tokuuye K; Ikeda H; Yajima M; Yamada T; Tanemura K; Tsunematsu R; Ohmi K
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):735-41. PubMed ID: 7860384
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.
    Shrivastava S; Mahantshetty U; Engineer R; Chopra S; Hawaldar R; Hande V; Kerkar RA; Maheshwari A; Shylasree TS; Ghosh J; Bajpai J; Gurram L; Gulia S; Gupta S;
    JAMA Oncol; 2018 Apr; 4(4):506-513. PubMed ID: 29423520
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High-dose-rate intracavitary irradiation using linear source arrangement for stage II and III squamous cell carcinoma of the uterine cervix.
    Kagei K; Shirato H; Nishioka T; Kitahara T; Suzuki K; Tomita M; Takamura A; Arimoto T; Matsuoka S; Mizoe JE; Sakuragi N; Fujimoto S; Miyasaka K
    Radiother Oncol; 1998 May; 47(2):207-13. PubMed ID: 9683371
    [TBL] [Abstract][Full Text] [Related]  

  • 74. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
    Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hyperfractionated external radiation therapy in stage IIIB carcinoma of uterine cervix: a prospective pilot study.
    Faria SL; Ferrigno R
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):137-42. PubMed ID: 9212015
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma.
    Ijaz T; Eifel PJ; Burke T; Oswald MJ
    Gynecol Oncol; 1998 Aug; 70(2):241-6. PubMed ID: 9740698
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Long-term result of high dose-rate afterloading brachytherapy in squamous cell carcinoma of the cervix: relationship between facility structure and outcome.
    Okuda T; Itho Y; Ikeda M; Nakamura T; Horikawa Y; Yanagawa S; Ishigaki T
    Jpn J Clin Oncol; 2004 Mar; 34(3):142-8. PubMed ID: 15078910
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
    Pötter R; Georg P; Dimopoulos JC; Grimm M; Berger D; Nesvacil N; Georg D; Schmid MP; Reinthaller A; Sturdza A; Kirisits C
    Radiother Oncol; 2011 Jul; 100(1):116-23. PubMed ID: 21821305
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Radiation therapy for squamous cell carcinoma of uterine cervix using high dose rate intracavitary irradiation].
    Ogawa Y; Sakamoto K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Oct; 54(12):1155-64. PubMed ID: 9261194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.